Reta$125
5 products
40 mg
MOTS-c is being researched for metabolic regulation, insulin sensitivity, and exercise responses in preclinical studies.
10 mg · 30 mg
Retatrutide is being researched for weight loss and blood sugar regulation through three hormone receptors.
50 mg
SS-31 (elamipretide) is being researched for mitochondrial function and cellular energy production.
20 mg
BPC-157 (Body Protective Compound 157) is being researched for tissue repair and recovery in preclinical studies.
70 mg
GLOW combines peptides individually researched for skin remodeling and tissue repair; evidence for the combined blend remains limited.
